BlackRock, Inc. Increases Stake in RxSight, Inc.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an increased ownership in RxSight, Inc. As of September 30, 2025, BlackRock holds 2,393,289 shares of RxSight's common stock, representing a 5.8% ownership stake. This marks an increase of 37,830 shares from the previous filing. The filing indicates that BlackRock has sole voting power over 2,356,084 shares and sole dispositive power over all 2,393,289 shares. The filing also notes that various persons have the right to receive dividends or direct the sale of the shares, but no single person's interest exceeds 5% of the total outstanding shares. The amendment was signed by Spencer Fleming, Managing Director, on October 17, 2025.